PMID- 26295162 OWN - NLM STAT- MEDLINE DCOM- 20160415 LR - 20211203 IS - 1935-2735 (Electronic) IS - 1935-2727 (Print) IS - 1935-2727 (Linking) VI - 9 IP - 8 DP - 2015 TI - Type 2 Diabetes Mellitus Is Associated with Strongyloides stercoralis Treatment Failure in Australian Aboriginals. PG - e0003976 LID - 10.1371/journal.pntd.0003976 [doi] LID - e0003976 AB - OBJECTIVE: To explore the efficacy of ivermectin in the treatment of serologically diagnosed cases of Strongyloides stercoralis (S. stercoralis) infection in an Aboriginal community and to describe factors that may influence the outcome of treatment. METHODS: Longitudinal study of a group of 92 individuals with serologically diagnosed S. stercoralis treated with ivermectin and followed up over a period of approximately 6 months. Main outcomes were serological titers pre and post treatment, diabetic status, and duration of follow up. FINDINGS: Treatment success was achieved in 62% to 79% of cases dependent on the methods employed for the diagnosis of infection and assessment of treatment outcome. Type 2 Diabetes Mellitus (T2DM) was found to be significantly associated with treatment failure in this group for two of the three methods employed. INTERPRETATION: Ivermectin has been confirmed as an effective treatment for S stercoralis infection in this setting. T2DM appears to be an independent risk factor for treatment failure in this population, and plausible mechanisms to explain this observation are presented. FAU - Hays, Russell AU - Hays R AD - Kimberley Aboriginal Medical Council, Broome, Western Australia, Australia; James Cook University, Cairns Campus, Smithfield, Queensland, Australia. FAU - Esterman, Adrian AU - Esterman A AD - Centre for Research Excellence in Chronic Disease Prevention, The Cairns Institute, James Cook University, Cairns Campus, Smithfield, Queensland, Australia; Sansom Institute of Health Service Research and School of Nursing and Midwifery, University of South Australia City East Campus, Adelaide, South Australia, Australia. FAU - McDermott, Robyn AU - McDermott R AD - Centre for Chronic Disease Prevention, Australian Institute of Tropical Health and Medicine, College of Public Health, Medical and Veterinary Sciences, James Cook University, Cairns, Queensland, Australia; School of Population Health, University of South Australia, Adelaide, South Australia, Australia. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150821 PL - United States TA - PLoS Negl Trop Dis JT - PLoS neglected tropical diseases JID - 101291488 RN - 0 (Antiparasitic Agents) RN - 70288-86-7 (Ivermectin) SB - IM MH - Administration, Oral MH - Animals MH - Antiparasitic Agents/administration & dosage/*therapeutic use MH - Australia/epidemiology MH - Diabetes Mellitus, Type 2/*complications/epidemiology/ethnology MH - Humans MH - Ivermectin/administration & dosage/*therapeutic use MH - Longitudinal Studies MH - *Native Hawaiian or Other Pacific Islander MH - Strongyloides stercoralis/*drug effects MH - Strongyloidiasis/*drug therapy MH - Treatment Failure PMC - PMC4546619 COIS- The authors have declared that no competing interests exist. EDAT- 2015/08/22 06:00 MHDA- 2016/04/16 06:00 PMCR- 2015/08/21 CRDT- 2015/08/22 06:00 PHST- 2015/03/13 00:00 [received] PHST- 2015/07/12 00:00 [accepted] PHST- 2015/08/22 06:00 [entrez] PHST- 2015/08/22 06:00 [pubmed] PHST- 2016/04/16 06:00 [medline] PHST- 2015/08/21 00:00 [pmc-release] AID - PNTD-D-15-00413 [pii] AID - 10.1371/journal.pntd.0003976 [doi] PST - epublish SO - PLoS Negl Trop Dis. 2015 Aug 21;9(8):e0003976. doi: 10.1371/journal.pntd.0003976. eCollection 2015.